Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • GE Healthcare to fund...

    GE Healthcare to fund health start-ups

    Written by savita thakur thakur Published On 2016-09-24T11:22:46+05:30  |  Updated On 24 Sept 2016 11:22 AM IST
    GE Healthcare to fund health start-ups

    Bengaluru : GE Healthcare announced funding global health start-ups to improve healthcare outcomes in developing economies.


    "Through our new accelerator five.eight, we will initially fund 10 startups with $5 million (Rs 33.5 crore) seed capital for each," said the $18-billion healthcare division of the US based GE (General Electric) in a statement here.


    The start-ups for funding will be evaluated on a case-by-case basis, with applicants sourced from the four social impact investors, but not limited to portfolio firms.


    Portfolio companies Acumen, Aavishkaar-Intellecap Group, Unitus Seed Fund and Villgro will be among the initial applicants for the first accelerator programme.


    "Each startup will focus on scaling healthcare innovations for emerging economies, with the potential for distribution of their product or integration of their service into our affordable care portfolio," said the healthcare behemoth in a statement here.


    The accelerator will target global health startups to improve healthcare quality and accessibility in developing or low-resource settings from education and training to disruptive, low-cost technologies and digital applications.


    "It's estimated that around 5.8 billion people across the world lack access to quality, affordable healthcare," said GE Healthcare Chief Executive John Flannery on the occasion.


    Admitting that the company alone cannot improve healthcare of those who need it most, Flannery said the goal of its accelerator (five.eight) was to fuel the global health ecosystem by partnering with social impact investors and health start-ups.


    Bengaluru based Tricog is the first startup to join five.eight accelerator. It focus on improving survival rates of heart attacks by decreasing the time between symptoms and treatment.


    "Using cloud-connected ECG devices in medical centres, Tricog helps doctors diagnose a patient within minutes of their arrival at a clinic, improving access to quick, accurate and affordable diagnosis, which can lead to mortality reduction," asserted the statement.


    The global firm will collaborate with Tricog to scale its solution to global markets.


    Five.eight joins GE's Innovation Network a global, connected ecosystem of accelerators, startups, and innovators working on technologies that disrupt and grow markets through digital transformation.


    "Startups joining five.eight will have access to our programming, resources and connectivity to our other innovation centres in Helsinki, Cardiff, Istanbul, Calgary, Johannesburg and Dubai,a noted the statement.A


    "Collaborating with investors allows us to work with entrepreneurs who have promising technologies to extend our portfolio of affordable solutions," said company's sustainable healthcare solutions President Terri Bresenham.


    The sustainable healthcare solutions develop affordable care portfolio of high value, low-cost technologies and healthcare delivery solutions for emerging markets.


    "Our goal is to define the next generation of care delivery technologies that can deliver impact where it matters," added Bresenham.

    Aavishkaar IntellecapGE HealthcareGeneral Electrichealth start-upsHealthcareJohn FlanneryTerri Bresenham
    Source : IANS

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    savita thakur thakur
    savita thakur thakur
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok